Masimo to Present at the Roth Capital Partners 21st Annual OC Growth Stock ...(detection and treatment of potentially l...),Health

Date:2/6/2009

detection and treatment of potentially life-threatening conditions. Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications." Additional information about Masimo and its products may be found at www.masimo.com.

    Masimo Corporation
    Investor Contact:                        Media Contact:
    Mark P. de Raad                          Dana Banks
    Executive Vice President                 Manager, Public Relations
    and Chief Financial Officer              Masimo Corporation
    Masimo Corporation                       (949) 297-7348
    (949) 297-7080                           dbanks@masimo.com
    mderaad@masimo.com

Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Radical-7, Rad-87, Rad-57,Rad-9, Rad-8, Rad-5, Pulse CO-Oximetry and Pulse CO-Oximeter are trademarks or registered trademarks of Masimo Corporation.

'/>"/>

SOURCE Masimo Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related medicine news :

1. Masimo to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 3, 2009
2. Masimo Files Patent Infringement Suit Against Philips
3. Clinicians at Dartmouth-Hitchcock Medical Center Present New Data Showing Masimo Rainbow SET(R) Oximetry and Patient SafetyNet(TM) Improves Patient Outcomes and Reduces the Cost of Care
4. Masimo to Present at Lazard Capital Markets 5th Annual Healthcare Conference
5. Masimo Launches First Non-adhesive Pulse Oximetry Sensor Designed For Extremely Low Birth Weight Babies
6. Masimo Reports Second Quarter 2008 Financial Results
7. Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
8. First Nursing Facility Installation of Masimo Patient SafetyNet(TM) Goes Live With Remarkable Results
9. Dartmouth-Hitchcock Medical Center Evaluation Findings Demonstrate Masimo Patient SafetyNet(TM) Delivers Improvements in Clinical Outcomes and Patient Safety on General Care Floors
10. Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin
11. Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry